Advertisement

Topics

KCI Licensing, Inc. Company Profile

22:42 EDT 22nd May 2019 | BioPortfolio

KCI’s innovative therapies make a difference in patients' lives every day. KCI’s therapies can be found helping patients recovering in all care settings. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes while helping to reduce the overall cost of patient care. Our products are backed by a worldwide network of service and clinical support.

Contact

Phone: 1-800-275-4524


News Articles [230 Associated News Articles listed on BioPortfolio]

Nuformix expands licensing agreement with NSB for NXP001

Nuformix has expanded its licensing agreement with its Chinese licensing partner Newsummit Biopharma (NSB) for NXP001, which is being developed...Read More... The post Nuformix expands licensing agree...

Novo Integrated Sciences and Novo Healthnet sign exclusive licensing agreement with Cloud DX

The Licensing Agreement provides NHL with perpetual licensing rights to the Bundled Pulsewave PAD-1A USB Blood Pressure Device, related software and up-to-date product releases. Additionally, the Lice...

Hikma Pharmaceuticals secures anti-viral licensing deal

It is an eight-year licensing deal covering the US market

Licensing deal to develop immuno-oncology treatments from antibodies

Sanofi and Biomunex Pharmaceuticals have entered a licensing agreement to develop new treatment options using bispecific and  -More- 

Roivant and iNtRON sign licensing deal for SAL200

Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which is an investigational biologic to...Read More... The post Roivant and iNtRON sign licensing...

STAT Plus: El Salvador is the latest Latin American country to worry pharma over compulsory licensing

Drug makers argue that compulsory licensing eviscerates patent rights.

United Therapeutics reaches $1.2bn licensing deal with Arena

Biotechnology company United Therapeutics has signed a licensing deal worth up to $1.2bn with biopharmaceutical firm Arena Pharmaceuticals for a...Read More... The post United Therapeutics reaches $1....

Dexcom, Verily amend licensing deal for next-gen CGM system

An amended licensing deal has been reached by Dexcom and Alphabet unit Verily Life Sciences for developing a second-generatio -More- 

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Fludeoxyglucose [the university of texas md anderson cancer center]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Sodium fluoride [kreitchman pet center]

These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injection. SODIUM FLU...

Sodium fluoride [precision nuclear llc]

These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injection. SODIUM FLU...

PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

Teen driver licensure provisions, licensing, and vehicular fatalities.

Between 1996 and 2015, vehicular fatalities per capita involving 16- to 17-year-old drivers declined by 68.7%. During this same period, states enacted teen driver licensure provisions in an á la cart...

Moral licensing, instrumental apology and insincerity aversion: Taking Immanuel Kant to the lab.

Moral licensing, equivalently called "self-licensing", is the instrumental use of a Good Act to cover up a Bad Act. This paper's thesis is that "instrumental apology" i.e., bad-faith apology, is a cas...

Driver licensing and motor vehicle crash rates among young adults with amblyopia and unilateral vision impairment.

This retrospective cohort study investigated whether unilateral vision impairment (UVI) or amblyopia are associated with driver licensing and crash risk among adolescents. Electronic health records fo...

An analysis and metric of reusable data licensing practices for biomedical resources.

Data are the foundation of science, and there is an increasing focus on how data can be reused and enhanced to drive scientific discoveries. However, most seemingly "open data" do not provide legal pe...

A 'community enterprise' model for recreational cannabis: Lessons from alcohol licensing trusts in New Zealand.

The legalisation of cannabis on the American continent in recent years has reinvigorated calls for cannabis law reform in many countries. Yet researchers have described potentially negative public hea...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Annual Study for Fluarix Registration

A pre-requisite to the yearly licensing process of the Influenza vaccine (FluarixTM/ Influsplit SSW®) is to demonstrate in clinical studies, the immunogenicity and reactogenicity of the v...

Yearly Strain Variation Study, 2010/2011

The purpose of the study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/201...

A Post-Marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Following licensing of PoliorixTM in Korea, this study will collect safety data about the routine use of this vaccine in 600 children according to the regulations of Korean Food and Drugs ...

StaphVAX Immunogenicity in Orthopedic Implant Patients

S. aureus is the most common pathogen involved in prosthetic joint infection. StaphVAX® is a vaccine to prevent these infections, which conjugates the purified capsular polysaccharides of...

Yearly Strain Variation Study, 2009/2010

The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Uni...

Companies [461 Associated Companies listed on BioPortfolio]

ProPharma Partners (UK)

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

The Licensing Executives Society, Inc.

Established in 1965, Licensing Executives Society (U.S.A. and Canada), Inc. (LES) is a professional society of 2,500 members engaged in the creation, commercial development, and o...

Propharma Partners Incorporated USA

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

AllianCat Tschannen - Pharma Research & Licensing Consultants

AllianCat delivers professional support to companies in the pharmaceutical, biotechnology and chemical arena by providing services for business development and licensing. The objective is to optimize ...

Innomedica Ltd

Innomedica Ltd. is an established international business development and licensing company focused on the Life Sciences. Innomedica provides professional services to biotechnology companies in three a...

More Information about "KCI Licensing, Inc." on BioPortfolio

We have published hundreds of KCI Licensing, Inc. news stories on BioPortfolio along with dozens of KCI Licensing, Inc. Clinical Trials and PubMed Articles about KCI Licensing, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KCI Licensing, Inc. Companies in our database. You can also find out about relevant KCI Licensing, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record